It confirms differential expression of IM (Cy-only) and MM (Cy, Ap, and Ec) and offers a basis to further explore the role of MUC5AC as a potential diagnostic, prognostic, and predictive biomarker in PDA. The gene discussed is MUC5AC; the disease is Patent ductus arteriosus.